L andmark legislation in 1972 extended Medicare coverage to nearly all patients with end-stage renal disease (ESRD) and established what still is the only diseasespecific federal entitlement program in the United States. 1 Owing to the federal government's prominent role in financing ESRD care, the ESRD program serves as a bellwether for new federal payment initiatives. In 2012, the Centers for Medicare & Medicaid Services (CMS) enacted the ESRD Quality Incentive Program (QIP), the first legislatively mandated pay-forperformance program. The ESRD QIP incorporates facility performance on an array of quality measures when determining reimbursement. 2, 3 As Medicare adopts more value-based payment models, [4] [5] [6] patient experience measures are becoming an important part of quality assessment initiatives. 7 In 2002, CMS collaborated with the Agency for Healthcare Research and Quality (AHRQ) to develop the In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH-CAHPS) survey, which became the first disease-specific patient experience survey used by CMS. 3, [8] [9] [10] [11] In 2016, ICH-CAHPS performance by dialysis facility was included as a clinical measure in the ESRD QIP, incorporating reports of patient experience into reimbursement calculations.
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A number of challenges exist to incorporating patient experience surveys in pay-for-performance programs, including the extent to which patient experiences measure an important dimension of the quality of care delivered, 13 how to best administer surveys, and whether to apply risk adjustment to account for patient [14] [15] [16] [17] and regional variation. [18] [19] [20] However, these surveys have the potential to introduce a patient-centered focus in quality assessment. 7 Early experiences with ICH-CAHPS surveys can help policy refinement on diverse issues. In this study we examined the associations of dialysis facility ICH-CAHPS scores with patient, dialysis facility, and geographic characteristics.
Methods

Data Sources
We obtained ICH-CAHPS scores from surveys administered at US dialysis facilities from April 8, 2015, through January 11, 2016, and available on the Dialysis Facility Compare (DFC) website. Regulations require that third-party vendors administer ICH-CAHPS surveys. We obtained dialysis facility characteristics from facility surveys included in the United States Renal Data System (USRDS) database and from 2015 DFC reports. Facility characteristics included membership within a large dialysis organization (LDO), defined as a chain with more than 200 facilities. We identified characteristics of patients receiving dialysis at each facility on December 31, 2014, from the USRDS database (the most recent date for which USRDS data were available to us). We linked dialysis facility zip codes to US Census-based information on population density and the following 2 geographic units: hospital service areas and hospital referral regions (HRRs), where dialysis facilities are nested within hospital service areas and hospital service areas are nested within HRRs. This project was approved by the institutional review board of Baylor College of Medicine, Houston, Texas, which waived the need for informed consent for the use of publicly available databases.
Because most ICH-CAHPS scores are obtained from patients with Medicare, a population with readily available administrative claims data, we identified demographic, socioeconomic, and health characteristics among patients with at least 3 months of Medicare Parts A and B coverage before the end of 2014. We ascertained patient comorbidities from International Classification of Diseases, Ninth Revision, diagnosis codes listed on the prior 6 months of Medicare claims and from CMS Medical Evidence Reports (form CMS-2728), which nephrologists are instructed to complete for patients initiating maintenance dialysis. For each patient, we calculated a comorbidity index derived from a Charlson Comorbidity Index modified for ESRD (eMethods in the Supplement). 21, 22 We merged data from the US Census to patient zip codes to approximate incomes. We calculated a commonly used metric of market competition between dialysis facilities (the Hirschman-Herfindahl Index) from information about patients receiving dialysis at the end of 2014, the hospital service areas where they lived, and dialysis facility ownership. This index is associated with the number of competing dialysis facilities from which patients can choose. 23 We calculated this index for each dialysis facility using a previously described method applied to study competition in health care markets, including markets for dialysis care (eMethods in the Supplement).
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Outcomes
The primary study outcome was the mean percentage of patients scoring their dialysis facility in the top box, or highest rating, across 6 patient experience and satisfaction categories, referred to as the mean ICH-CAHPS score. In this way, the ICH-CAHPS survey is incorporated into facility QIP scores. Three categories were composites of questions about nephrologists' communication and care, dialysis center care and operations, and provision of information to patients, whereas 3 were overall ratings of satisfaction with nephrologists, dialy-sis center staff, and dialysis facilities (Box). We also examined facility scores on each of the 6 component categories. Dialysis facilities with fewer than 30 adults receiving incenter hemodialysis are exempt from administering the ICH-CAHPS survey, whereas facilities that do not successfully administer 30 surveys are not given an ICH-CAHPS score. We examined the likelihood of qualifying facilities not meeting the threshold of 30 successfully completed surveys and refer to these as facilities with a missing ICH-CAHPS score. We also examined geographic variation in facilities' mean ICH-CAHPS scores.
Study Exposures and Covariates
Our objective was to compare the associations of facility ICH-CAHPS scores with patient (10% difference), dialysis facility, and geographic characteristics listed in Table 1 and  Table 2 . We used HRRs to define each facility's catchment area.
Statistical Analyses
Data were analyzed from September 15, 2017, through June 1, 2018. We used multivariable mixed-effects linear regression models to examine the associations of facility ICH-CAHPS scores and patient, dialysis facility, and geographic characteristics. When examining the likelihood of a facility having a missing ICH-CAHPS score, we used logistic regression. In each regression model, we included the HRR where facilities were located as a random effect. All models included covariates listed in Table 1 and Table 2 , with continuous covariates divided into categories to allow for nonlinear associations. We used a 2-tailed P < .05 as a measure of statistical significance.
To examine geographic variation in facilities' ICH-CAHPS scores, we calculated the mean facility ICH-CAHPS scores within each HRR. We described variation in scores across HRRs and mapped quartiles of mean ICH-CAHPS scores across the United States. We also used a series of nested linear regression models to approximate the amount of total variance in facility ICH-CAHPS scores explained by patient characteristics, observed facility and geographic characteristics, and geographic location (eMethods in the Supplement).
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Results
Baseline Characteristics
Of 4977 US dialysis facilities with information from 2015 and early 2016 on the DFC website and identifiable characteristics, 2939 (59.1%) reported mean ICH-CAHPS scores. Among these facilities, the mean facility ICH-CAHPS score was 65.8% (SD, 8.3%; interquartile range, 60.3%-71.5%) (eFigure 2 in the Supplement). Facilities in the top 50th percentile of mean facility ICH-CAHPS scores cared for more white and Asian and older patients as well as more patients with private group health insurance, multiple medical comorbidities, less than 1 year of dialysis, and higher incomes. These higher-scoring facilities also cared for fewer patients who were black and who were eligible for Medicaid; they were smaller, had more nurses, technicians, and dialysis chairs per patient, and were in areas with less market competition (Table 1) . Of the remaining 2038 (40.9%) facilities with missing ICH-CAHPS scores, 784 (38.5%) had fewer than 30 patients (eTable 2 in the Supplement).
Compared with nonprofit facilities, scores of for-profit facilities were lower by 4.2 percentage points; compared with hospital-based facilities, those of free-standing facilities were lower by 6.4 percentage points; and compared with independent or small-chain facilities, those of LDO facilities were lower by 2.6 percentage points (P < .001 for all comparisons). Compared with metropolitan facilities, scores were 2.3 percentage points higher for facilities in small towns, 1.4 percentage points higher for micropolitan facilities, and 0.4 percentage points lower for rural facilities (P = .002 for test of joint significance). Among facilities with nonmissing ICH-CAHPS scores, 2606 (88.7%) were for-profit, 2015 (68.6%) were owned by LDOs, 2825 (96.1%) were free-standing, and 104 (3.5%) were in small towns. Of all facilities, 1898 (64.6%) were owned by for-profit LDOs, all of which were free-standing (Table 2) .
Primary Regression Results
The multivariable regression model identified several patient characteristics that were independently associated with facility ICH-CAHPS scores. Mean ICH-CAHPS scores were lower by 0.95 percentage points (95% CI, 0.78 to 1.12) in facilities caring for higher proportions of black patient populations and by 1.00 percentage point (95% CI, 0.39 to 1.60) in facilities caring for larger Native American patient populations compared with facilities treating white patients. Facilities caring for higher proportions of privately insured patients had mean ICH- Figure 1 ). Although having a larger proportion of patients in the third quartile of median income was associated with lower facility ICH-CAHPS scores, this finding did not persist in a sensitivity analysis (eMethods in the Supplement). 
Missing ICH-CAHPS Scores
Variation in Facility ICH-CAHPS Scores
The mean score among facilities in the top quartile of HRRs was 74%, compared with 61% among facilities in the bottom quartile of HRRs (P < .001) ( Figure 2 ). Although facility ICH-CAHPS scores varied across HRRs, we did not observe clustering of ICH-CAHPS performance within broader geographic regions. Our primary regression model explained 27% of the total observed variation in ICH-CAHPS scores among facilities. Facility locations (modeled as HRR random effects), patient characteristics, and observable facility and geographic characteristics independently accounted for 34%, 9%, and 18% of the total explained variation, respectively, whereas overlap among these 3 categories accounted for approximately 38% of the remaining explained variation. Separate models, including patient characteristics or facility locations alone, accounted for 45% and 60%, respectively, of the total explained variation (eTable 1 and eFigure 1 in the Supplement).
Additional Analyses
In companion multivariable models, predictors associated with the 6 individual components constituting the mean facility ICH-CAHPS score generally had the same direction of association as predictors associated with mean facility ICH-CAHPS scores, although not all predictors remained statistically significant. Several differences in the companion models were notable. A larger Hispanic population undergoing dialysis was associated with lower scores in the dialysis center care and operations composite (−0.26; 95% CI, −0.49 to −0.03), whereas larger Asian (−0.40; 95% CI, −0.68 to −0.11) and Hispanic (−0.46; 95% CI, −0.62 to −0.29) populations were associated with lower scores in the composite of providing information to patients and in the overall ratings of dialysis center staff. "Overall ratings of dialysis center staff" are different from the "composite of providing information to patients" (−0.43; 95% CI, −0.78 to −0.08, and −0.76; 95% CI, −1.36 to −0.16, respectively). Less market competition was associated with better scores on the providing information to patients composite (3.08; 95% CI, 1.85-4.31) as well as global ratings of facilities (OR, 2.64; 95% CI, 0.01-5.28) and center staff (OR, 2.66; 95% CI, 0.10-5.22) (eTables 4 and 5 in the Supplement).
Discussion
We found that dialysis facility characteristics and geographic location were strongly associated with facility ICH-CAHPS scores. Mean scores for dialysis facilities that were for-profit or free-standing or that belonged to LDOs were lower by 1.6 to 2.6 percentage points, independently of other observable characteristics; based on these estimates, for-profit LDO facilities would be independently associated with mean scores lower by 4.2 percentage points. Facilities with more nurses per patient had better ICH-CAHPS performance. Among patient characteristics that were significantly associated with ICH-CAHPS scores, the proportion of patients of minority race/ ethnicity had the largest estimated effects. Although 41.0% of facilities did not report ICH-CAHPS surveys, more than half of these facilities had the requisite number of patients to qualify for the performance measure had they successfully obtained 30 survey responses during the year. Although patient experience scores are increasingly used to evaluate and compare health care providers, debate is on- Results were selected from the multivariable mixed regression model (Table 3 ). All factors that were associated with the mean ICH-CAHPS score with P <.05 were included.
a Reference group. b The reference group is number of nurses per 100 patients in 2014.
Research Original Investigation
Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System going about what constitutes a minimally important difference in scores. A recently published systematic review identified 3 general approaches that have been used to define a minimally important difference in group-level patient experience scores. These include comparing an observed score difference against the overall distribution of scores in the population, an external anchor known to be important to patients, and the differences observed in association with other important covariates. 27 By all of these criteria, the differences in ICH-CAHPS scores that we observed among different dialysis facility characteristics would be considered meaningful. For example, if a low-scoring dialysis facility were to improve its performance by 4.0 percentage points (or an SD of 0.5), it could rise 18 percentile points in its relative rank. Similar-or smaller-differences in patient experience scores were considered relevant in a comparison of hospitals and were found to correlate with patients' disenrollment from health plans and choices of primary care physicians. [28] [29] [30] Further evaluating the extent to which patient-experience scores reported at the dialysis facility level reflect meaningful differences in care delivery will be increasingly important. Our finding that reported mean patient experience scores are lower at facilities that are for-profit, free-standing, and part of an LDO is consistent with economic theory predicting that nonprofit health care providers place a greater emphasis on quality 31 and with prior studies examining the associations among dialysis provider characteristics and other potential dimensions of care quality. 24, 32 For example, mortality rates may be higher among patients undergoing dialysis at large dialysis chains, 32 and patients undergoing dialysis at for-profit facilities spend more time in the hospital. 24 Although our findings raise concern that differences in care delivery may also contribute to lower reported experiences at for-profit, freestanding, and LDO facilities, the connection between patient experiences and the quality of care delivered by health care providers is also uncertain.
13,14,33-36
The role that geography plays in patient experience can inform efforts for risk adjustment of ICH-CAHPS survey scores. Ongoing efforts are examining inputs for equitably riskadjusting quality measures. 37, 38 Similar to prior analyses of quality in ESRD care that failed to detect differences in traditional quality measures across observed geographic characteristics, 39-41 we did not identify significant associations between facility ICH-CAHPS performance and most observed geographic characteristics. However, geographic location accounted for a substantial proportion of the total explained variation in ICH-CAHPS scores, suggesting that unobserved geographic factors, such as patients' cultural and social preferences or regional differences in reimbursement incentives, 42,43 influence facility performance. To the extent that these unobserved geographic features are outside a dialysis facility's control, this finding supports the use of geographic risk adjustment to "level the playing field" across US dialysis facilities. One approach to handle unobserved geographic differences in reporting patient experiences would be to compare dialysis facilities with other facilities operating in a similar region, as in some Medicare Shared Savings programs. 44 We identified several areas where the survey's implementation within the ESRD QIP could be improved. Only 59.1% of US dialysis facilities had complete (or nonmissing) ICH-CAHPS scores. When analyzing factors associated with missing scores, we found that facilities that were smaller, cared for sicker populations, had more immobile patients, and had a higher proportion of patients requiring Medicaid coverage because of poverty or disability were significantly more likely to have missing survey responses, suggesting that specific patient populations may be less likely to respond to surveys. Although smaller facilities also had higher ICH-CAHPS scores, the sizeable number of smaller facilities with no score may have confounded this association. This bias would occur if the likelihood of having a missing score among smaller facilities is inversely associated with patient satisfaction. Future iterations of the ICH-CAHPS survey should aim to improve response rates in these facilities.
The observed associations of race and ethnicity with facility performance on ICH-CAHPS scores highlight an opportunity to improve patient experiences. We found that facilities with more black and Native American patients received lower scores on patient experience, consistent with evaluations of the CAHPS patient experience survey for home health services. 45 We also found that facilities with larger proportions of Hispanic and Asian patients (for whom English is often a nonprimary language) received poorer scores on facility communication. This variation in communication scores among racial and ethnic minorities is consistent with other (nondialysis) CAHPS surveys. 46 These findings underscore the potential influences of socioeconomics, cultural differences, and beliefs on experience reporting and highlight an important opportunity for dialysis providers to improve care delivered to racial and ethnic minorities.
Limitations
This study included a national patient cohort. We leveraged comprehensive sources of patient, geographic, and facility information to account for many observed factors, including metrics of market competition. However, several limitations should be noted. We aggregated the characteristics of patients receiving dialysis from the most recent USRDS data available (December 2014) but used these characteristics to compare the scores reported from surveys administered in 2015 and early 2016. Although unlikely, we cannot exclude the possibility of meaningful changes in patient characteristics within facilities during 2015. The aggregate survey results from the DFC website did not include the number of individual survey respondents at each facility, which could disadvantage dialysis facilities with smaller patient populations. In addition, the DFC data did not allow us to determine predictors associated with individual patient scores, increasing the risk of erroneous associations resulting from the process of aggregation. When considering our results in the broader policy context, however, CMS uses facility-level data to calculate facility QIP scores, which aligns our vantage point with that of national policymakers. Certain patients may be more or less likely to complete the ICH-CAHPS survey, and survey administration methods may vary, which may lead to bias. We did not have information about self-reported health, which has been associated with ICH-CAHPS scores and is currently used by CMS in other health care settings to risk adjust CAHPS performance. 47 Finally, the method used to decompose variance in ICH-CAHPS scores has limitations, including the possibility of overfitting the data.
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Conclusions
Our study represents an initial investigation of how patient, facility, and geographic characteristics are associated with dialysis facility performance on reporting of patient experience in the US ESRD pay-for-performance program. Our findings raise concern about perceived patient experiences at forprofit, free-standing dialysis facilities and LDOs and about the perceived quality of care provided to certain racial and ethnic populations. They suggest that staffing facilities with more nurses may lead to improvements in patient experience scores. This study also highlights the potential value of risk adjustment for unobserved geographic factors and the need for more effective survey administration among smaller facilities caring for elderly, at-risk populations. These results reveal an opportunity for evaluation-informed policy refinement in the evolution of Medicare payment reform. We defined comorbid conditions using ICD-9 codes and procedure codes from ≥1 inpatient or ≥2 outpatient encounters separated by at least one day in the three-to-six months prior to (but not including) the index date (December 31, 2014). A modified Charlson score was obtained using the following algorithm:
1) 1 point was assigned to the following comorbidities: peripheral vascular disease, dementia, chronic lung disease, rheumatological disease, peptic ulcer disease, diabetes. 2) 2 points were assigned to the following conditions: myocardial infarction, congestive heart failure, cerebral vascular disease, liver disease, cancer, HIV, and hemiplegia.
Cerebrovascular disease included diagnoses of central nervous system bleed, central nervous system vascular disease, stroke, or transient ischemic attack. Peptic ulcer disease included patients with diagnosed peptic ulcer disease along with diagnosed gastrointestinal bleed. Myocardial infarction included patients diagnosed with an acute myocardial infarction, a history of a coronary bypass or percutaneous coronary intervention, and a history of unstable angina. Heart failure included patients with diagnosed heart failure along with valvular disease. Chronic lung disease included patients with diagnosed lung disease or pulmonary hypertension. We assumed a diagnosis of liver disease was moderate or severe. Because of difficulty ascertaining complications from diabetes using claims, we assigned 1 point for all diagnoses of diabetes.
In an effort to retain as much information as possible, we combined some elements of the modified Charlson comorbidity index with the original Charlson comorbidity index. Specifically, our calculation deviated from the modified Charlson morbidity index described by Hemmelgarn et al. in the following ways 1 :
1) Since we did not have reliable information on the type of cancer, we assigned 2 points to a diagnosis of cancer (which is what the original Charlson comorbidity index assigns for neoplasia), and did not include separate point scores for lymphoma or metastatic disease. 2) We assigned 2 points for hemiplegia, which is what is used in the original Charlson comorbidity index (the modified index did not include hemiplegia due to insufficient data).
3) The modified Charlson comorbidity index did not include HIV due to insufficient data.
Because we had information about HIV, we included it in our comorbidity index. However, the original Charlson comorbidity index assigned "AIDS" a value of 6. Since that time, mortality associated with HIV has declined substantially in the general population and among patients with end-stage renal disease. In one cohort, the relative risk of death declined by 78% over more than two decades. 2 To account for this decline in relative risk of death, we assigned patients with a diagnosis of HIV 2 points.
Calculating Metric of Market Competition:
The equation used to calculate Herfindahl-Hirschman Index (HHI) is as follows:
Where S i represents the proportion of patients living in a Hospital Service Area (HSA) receiving dialysis at the i th firm in the HSA.
We adapted a model of market competition that is based off of HSAs but that also accounts for some patients' decisions to receive dialysis in different HSAs. Specifically, we used the following steps to calculate a measure of observed HHI for each dialysis facility based on where patients received dialysis on December 31, 2014:
1. Calculate a "first-stage" competition measure for each HSA where patients live (using the equation above), based on market shares of firms where patients living in each HSA choose to dialyze. In this stage all patients residing in a given HSA define the "market" for each firm-HSA pair. Firms do not have to be located in the same HSA where patients reside, and a given dialysis facility can be included in the calculation of HHI for multiple HSAs if patients from multiple HSAs dialyze at that facility. For the purposes of this step, facilities owned by the same dialysis chain were considered to be one firm, reflecting the likelihood that they do not directly compete against one another for patients due to shared ownership. The market share for a firm in an HSA is equal to the proportion of patients in that HSA who choose to dialyze at that firm. For example, in an HSA where half of the patients receiving dialysis went to one of four facilities owned by one firm and the other half of patients went to one of two facilities owned by a second firm, the market share would be considered to be split evenly across the two firms, with an HHI for that HSA of 0.5 2 + 0.5 2 = 0.5.
2. Calculate a dialysis-facility-level measure of competition, using a weighted average of the "first-stage" HSA-level HHIs for patients who dialyze at each facility. This measure is calculated for each separate facility, regardless of which firm owns a facility. It assumes that facilities compete for patients within HSAs and can discriminate upon patients living in different HSAs when competing against rival firms.
In summary, this dialysis facility-specific index represents a weighted average of competition indices for patients that each facility treats. This index of market competition assumes that facilities can discriminate upon patients residing in different HSAs when determining how much competition they face. It also assumes that facilities owned by the same organization can modify their practices based on the amount of competition that they face locally. Because this index is based on where patients receive dialysis on one day of each year, it does not incorporate information about patients who switch dialysis units during a year.
Variance Decomposition Analysis:
In a variance decomposition analysis, we determined the amount of the total population variance explained by different categories of observable characteristics and Hospital Referral Region (HRR) random affects as determined by the R 2 from different regression models, where R 2 is represented by the following equation:
In our case, illustrated above is the estimated patient experience score for the i th facility in the j th hospital referral region according to the model 'm' that includes different combinations of patient, facility and geographic characteristics in addition to hospital HRR random effects.
This method of decomposing variance in the context of mixed regression models was described by Brookhart et al. 3 as well as others. It involves using a series of nested mixed regression models to estimate variance components. In order to ensure that all models would share the same overall variance, we only included mixed regression models with Hospital Referral Region (HRR) random effects.
To conduct the variance decomposition analysis, we first assessed a mixed linear regression model with ICH-CAHPS scores as the outcome, an intercept, and HRR random effects. This initial "intercept-only" model did not include any other covariates and is illustrated in Equation  1 below.
Intercept only model:
( The intercept only model yielded estimates of the variance associated with the HRR random effects and the variance associated with the residuals (See table S1). We used these estimates to identify the total variance in the population within the mixed regression framework using Equation 2 below:
Relationship among variances: (2)
The intercept-only model also enabled us to estimate the R 2 associated with geographic random effects prior to inclusion of observable fixed effects using Equation 3 below:
Estimating R 2 for random effects:
We then ran a series of nested mixed effect models using ICH-CAHPS scores as the outcome of interest including observed characteristics as fixed effects and HRR random effects. 
Mixed effect model: (4)
where X ij represents observed characteristics in the ith facility and jth HRR.
In each nested model, we used the variances associated with the residual and HRR random effects, in addition to the total variance in the population (Var total.1 from the intercept-only model described above) to calculate the R 2 associated with that nested model's various components. Specifically, the R 2 of the components included in each nested model ' ' were calculated from the following Equations 5, 6, and 7:
Nested linear mixed models:
fixed effects refers to the amount of the total population variance explained by observed patient, dialysis facility, and geographic fixed effects included in each nested model ' '. These fixed effects varied with each model, depending on what set of characteristics we included in a given model. R 2 HRR describes the amount of total population variance explained by HRR random effects in each nested model. This value varied for each nested model, as it was obtained after accounting for the explanatory value of fixed effects.
The three nested regression models are described below. Each model controlled for HRR random effects. Note: Subscripts `i' and `j' refer to facility 'i' and Hospital Referral Region (HRR) 'j'. The variance of the HRR effect is calculated after accounting for explanatory value of "fixed effects". In this case, "fixed effects" refers to observable patient characteristics ("X") or observable dialysis facility and geographic characteristics ("Y"). The amount of total explained variance accounted for by each R 2 is equal to the R 2 /0.27. The last column illustrates the total variance explained for each nested model.
Calculations involving dialysis facility location:
We used the three sets of R 2 estimates ("A", "B", and "A+B") described above to calculate the size of each space in a Venn diagram (exemplified in Figure S1 ), which we then used to identify the amount of total variance explained by each component of our analysis. The following equations illustrate how results listed in Table S1 (above) were used to estimate the size of each space in a Venn diagram exemplified in Figure S1 , where 'A' represents variance explained by observable patient characteristics, 'B' represents variance explained by observable facility and geographic characteristics, and 'C' represents variance explained by HRR random effects: 
Examining the association between median income and Mean ICH-CAHPS score:
In our primary analysis, we found that facilities with a larger proportion of patients in the 3 rd quartile of median income had slightly lower ICH-CAHPS scores. In particular, there was a reduction of 0.34 in ICH-CAHPS score (95% CI 0.18 to 0.50) for every 10% increase in the proportion of patients living in zip-codes in the 3 rd quartile of median income. Due to known geographic biases associated with use of zip-code median income as a measure of socioeconomic status, we conducted a sensitivity analysis where we substituted quartile of median income with quartile of the percent of adults in a zip-code with at least a high-school education. This is also available from the U.S. Census, and is commonly used as a less biased proxy for socio-economic status. In this sensitivity analysis, we did not find a significant association between high-school education and ICH-CAHPS score. This suggests that the association between median income and ICH-CAHPS score may be due to factors other than patient socioeconomics.
We examined possible reasons why median income might be associated with ICH-CAHPS scores by examining each observed patient, facility, and geographic characteristics among patients in each quartile of median income. There were a number of trends that continued in the same direction with increasing quintile of income. For example, the proportion of patients who were White and who lived in metropolitan areas increased with each quartile of median income, while the proportion of patients who were dual-eligible for Medicaid and who were female declined with each increase in median income quartile. However, several characteristics had unique patterns that were more specific to the 3 rd income quartile. For example, the third quartile of median income had more patients aged 50-64 than the 1 st two and 4 th quartiles of median income. And, the proportion of patients with more than two years on dialysis was constant across the first three income quartiles, but declined in the 4 th quartile of income. The proportion of patients living in Micropolitan areas increased with higher income quartiles, before decreasing sharply among patients in the highest income quartile.
These non-monotonic trends across income quartiles suggest that certain patient and geographic characteristics may have complex associations with income. To the extent that our model did not sufficiently control for these associations, this could lead to erroneous observations in the association between median income and ICH-CAHPS score. 
